Upload File

als drug summary

1
ALS Pharmacology Summary Drugs indicated for use in Advanced Life Support cases[1] [1] Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, Kudenchuk PJ, Ornato JP, McNally B, Silvers SM, Passman RS, White RD, Hess EP, Tang W, Davis D, Sinz E, Morrison LJ. "Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". Circulation. 2010;122:S729-S767. http://circ.ahajournals.org/ content/122/18_suppl_3/S729.full [2] Physicians' Desk Reference (65th ed.). Montvale, NJ: PDR Network. [3] DailyMed, National Library of Medicine, National Institutes of Health. June 2013 (Apr. 10, 2014).http://dailymed.nlm.nih.gov/dailymed/ drugInfo.cfm?id=99376 Design (C) 2014 ACLS Training Center. Drug brand names are trademarks or registered trademarks of their respective owners. Adenosine (Adenocard) 15-30°C (59-86°F) Do not refrigerate Amiodarone (Cordarone) 20-25°C (68-77°F) Protect from light Atropine Sulfate (Hospira Inc.) 20-25°C (68-77°F) Dopamine (Dopamine HCl) 20-25°C (68-77°F) Avoid excessive heat. Protect from freezing. Epinephrine (EpiPen) 20-25°C (68-77°F) Protect from light. Do not refrigerate. Lidocaine (Xylocaine-MPF) 20-25°C (68-77°F) Protect from light. Magnesium Sulfate (Ansyr)[3] 20-25°C (68-77°F) Vasopressin (Desmopressin Acetate) 20-25°C (68-77°F) Drug Storage[3] For high-quality online ACLS training please call us at 877-560-2940 or www.acls.net/promo/medikool Saline (0.9% NaCl)[1] 25°C (77°F) Administer 4°C (39°F) for therapeutic hypothermia

Upload: pramod-sharma

Post on 11-Jul-2016

216 views

Category:

Documents


1 download

Report

DESCRIPTION

Short summary of storage of drugs used in Advanced Life Support protocols

TRANSCRIPT

Page 1: ALS Drug Summary

ALS Pharmacology SummaryDrugs indicated for use in Advanced Life Support cases[1]

[1] Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, Kudenchuk PJ, Ornato JP, McNally B, Silvers SM, Passman RS, White RD, Hess EP, Tang W, Davis D, Sinz E, Morrison LJ. "Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". Circulation. 2010;122:S729-S767. http://circ.ahajournals.org/content/122/18_suppl_3/S729.full[2] Physicians' Desk Reference (65th ed.). Montvale, NJ: PDR Network.[3] DailyMed, National Library of Medicine, National Institutes of Health. June 2013 (Apr. 10, 2014).http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=99376

Design (C) 2014 ACLS Training Center. Drug brand names are trademarks or registered trademarks of their respective owners.

Adenosine(Adenocard)

15-30°C (59-86°F)Do not refrigerate

Amiodarone(Cordarone)

20-25°C (68-77°F)Protect from light

Atropine Sulfate(Hospira Inc.)

20-25°C (68-77°F)

Dopamine(Dopamine HCl)

20-25°C (68-77°F)Avoid excessive heat. Protect from freezing.

Epinephrine(EpiPen)

20-25°C (68-77°F)Protect from light. Do not refrigerate.

Lidocaine(Xylocaine-MPF)

20-25°C (68-77°F)Protect from light.

Magnesium Sulfate(Ansyr)[3]

20-25°C (68-77°F)

Vasopressin(Desmopressin Acetate)

20-25°C (68-77°F)

Drug Storage[3]

For high-quality online ACLS training please call us at 877-560-2940 or www.acls.net/promo/medikool

Saline(0.9% NaCl)[1]

25°C (77°F)Administer 4°C (39°F) for therapeutic hypothermia

Medicaid Drug Utilization Review State Comparison/Summary

World Drug Report 2010 Summary

200063Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 200063orig1s000 summary review

Drug Policy Modelling Project · 2012-02-28 · DRUG POLICY MODELLING PROGRAM . MONOGRAPH 16. A SUMMARY OF DIVERSION PROGRAMS . FOR DRUG AND DRUG-RELATED OFFENDERS IN AUSTRALIA

FY 2014 BUDGET AND PERFORMANCE SUMMARY - … · NATIONAL DRUG CONTROL STRATEGY: FY 2014 Budget and Performance Summary 7 Executive Summary In support of the 2013 National Drug Control

Your Monthly Prescription Drug Summary - … Monthly Prescription Drug Summary . ... (TTY Spanish) Customer Services ... STAGE 1 : Yearly Deductible

NCCP Regimen Information Summary - by Drug Last updated

Drug Shortages Summit Summary Report

Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey€¦ · Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey California Environmental Protection

Prescription Opioids (Canadian Drug Summary) Library/CCSA-Canadian-Drug-Summary... · higher for young adults aged 20–24 at 12.8%.7 Adults (age 25+): ... Canadian Drug Summary:

2016 Prescription Drug Abuse Summit Summary At …gov.nv.gov/uploadedFiles/govnvgov/Content/News_and_Media/...2016 Prescription Drug Abuse Summit Summary At A Glance Governor’s Prescription

Ropinirole, a New ALS Drug Candidate Developed Using iPSCs · Review Ropinirole, a New ALS Drug Candidate Developed Using iPSCs Hideyuki Okano,1,* Daisuke Yasuda,2 Koki Fujimori,1

KINDReD Final Report: Publishable summary Executive summary · KINDReD Final Report: Publishable summary Executive summary The Kinetoplastid Drug Development (KINDReD) consortium

Mechanisms of drug hypersensitivity KDIGOkdigo.org/.../02/12.-Bircher_Mechanisms-of-Drug-Hypersensitivity-.pdf · Mechanisms of drug hypersensitivity ... Summary iron hypersensitivity

202806Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 202806orig1s000 summary review

H.R. 3 - Drug Price Negotiation Bill Summary 3 Drug Pricing Proposal... · H.R. 3 Title Summary TITLE I - Drug Price Negotiation Drug Selection Process k • ff 'th the Every year

204042Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 204042orig1s000 summary review

Clandestine Drug Laboratories in South Australia: Summary

Summary of Drug Limitations - WellCare

RICK SCOTT GOVERNOR SUMMARY OF DRUG LIMITATIONS

Bill Title Sponsor Summary · 2019. 4. 9. · Bill Title Sponsor Summary HB 19 Prescription Drug Importation Programs Leek Prescription Drug Importation Programs: Creates programs

1004 BLS/ALS Adult Drug Formulary

Boksmart 2010-Recreational Drug Summary - SA Rugby 2010-Recreational Drug... · Recreational Drug Summary Chart 4 DRUG APPEARANCE & PRESENTATION ... / soap / grievous bodily harm

Ontario Drug Benefit Formulary/Comparative Drug Index · 1 . Ontario Drug Benefit . Formulary/Comparative Drug Index . Edition 43 . Summary of Changes – January 2020 . Effective

Drug Rediscovery als innovatief concept Collegedag 8 juni 2011

Summary Report on EU Drug Precursors Seizures 2008

The Multi-Site Adult Drug Court Evaluation: Executive Summary

Methamphetamine (Canadian Drug Summary)...Canadian Drug Summary: Methamphetamine Canadian Centre on Substance Use and Addiction • Centre canadien sur les dépendances et l’usage

203109Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 203109orig1s000 summary review

Drug Rediscovery als innovatief concept

Ontario Drug Benefit Formulary/Comparative Drug Index · 2020. 3. 24. · 1 . Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 . Summary of Changes – March 2020

Comparison/Summary Report FFY 2012 Medicaid Drug Utilization Review Annual … · 2015. 7. 1.  · Comparison/Summary Report FFY 2012 Medicaid Drug Utilization Review Annual Report

Healthy Montgomery Core Measures Data Summary Healthy ... › healthy...9 Healthy Montgomery Core Measures Data Summary DRUG-INDUCED MORTALITY Drug-Induced Mortality Age-Adjusted Rates,

2013 Novel New Drugs Summary - Food and Drug Administration

Alcohol (Canadian Drug Summary) - Canadian Centre on ... Library/CCSA-Canadian-Drug-Summary-Alcohol... · Canadian Drug Summary: Alcohol Canadian Centre on Substance Use and Addiction